Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P England

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Mbio|August 22, 2023
New insight into flavivirus maturation from structure/function studies of the yellow fever virus envelope protein complexE Crampon, E Covernton, M C Vaney, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 24, 2000
A potent dimeric peptide antagonist of interleukin-5 that binds two interleukin-5 receptor alpha chainsB P England, P Balasubramanian, I Uings, et al.
Nature Biotechnology|February 3, 2005
A family of phosphodiesterase inhibitors discovered by cocrystallography and scaffold-based drug designGraeme L Card, Landy Blasdel, Bruce P England, et al.
Science (New York, N.Y.)|November 4, 2017
A glycerophospholipid-specific pocket in the RVFV class II fusion protein drives target membrane insertionP Guardado-Calvo, K Atkovska, S A Jeffers, et al.
Structure (London, England : 1993)|December 4, 2004
Structural basis for the activity of drugs that inhibit phosphodiesterasesGraeme L Card, Bruce P England, Yoshihisa Suzuki, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 2009
Scaffold-based discovery of indeglitazar, a PPAR pan-active anti-diabetic agentDean R Artis, Jack J Lin, Chao Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 8, 2022
Evaluation of individual and ensemble probabilistic forecasts of COVID-19 mortality in the United StatesEstee Y Cramer, Evan L Ray, Velma K Lopez, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Mbio|August 22, 2023
New insight into flavivirus maturation from structure/function studies of the yellow fever virus envelope protein complexE Crampon, E Covernton, M C Vaney, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 24, 2000
A potent dimeric peptide antagonist of interleukin-5 that binds two interleukin-5 receptor alpha chainsB P England, P Balasubramanian, I Uings, et al.
Nature Biotechnology|February 3, 2005
A family of phosphodiesterase inhibitors discovered by cocrystallography and scaffold-based drug designGraeme L Card, Landy Blasdel, Bruce P England, et al.
Science (New York, N.Y.)|November 4, 2017
A glycerophospholipid-specific pocket in the RVFV class II fusion protein drives target membrane insertionP Guardado-Calvo, K Atkovska, S A Jeffers, et al.
Structure (London, England : 1993)|December 4, 2004
Structural basis for the activity of drugs that inhibit phosphodiesterasesGraeme L Card, Bruce P England, Yoshihisa Suzuki, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 2009
Scaffold-based discovery of indeglitazar, a PPAR pan-active anti-diabetic agentDean R Artis, Jack J Lin, Chao Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 8, 2022
Evaluation of individual and ensemble probabilistic forecasts of COVID-19 mortality in the United StatesEstee Y Cramer, Evan L Ray, Velma K Lopez, et al.
Pageof 7